On April 16, the Nasdaq Stock Market issued Nasdaq Issuer Alert 2020-2, announcing a proposal for temporary relief for companies listed on the exchange with respect to stock prices and market values that have fallen below...more
More than ever, life sciences companies are going public to raise capital for future growth. In fact, U.S. equity financing in life sciences skyrocketed to a record $7 billion in 2018—a 69 percent jump over the year...more
2/8/2019
/ Accounting Standards ,
Capital Formation ,
Capital Markets ,
Disclosure Requirements ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Internal Controls ,
Investment Banks ,
Life Sciences ,
Popular ,
Regulatory Standards ,
Reporting Requirements ,
Sarbanes-Oxley ,
Startups ,
Stock Exchange ,
Transparency